PMH35 - Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia
| Autor: | Amezquita, M, Alzate, M, Cordoba, R, Oviedo, G, Lopez-Jaramillo, C, Guerrero, E, Aguirre, A |
|---|---|
| Zdroj: | In Value in Health May 2018 21 Supplement 1:S185-S185 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect